Testing for hepatitis C virus infection in UK prisons: What actually happens?
Testing for hepatitis C virus infection in UK prisons: What actually happens?
复制标题
DOI：
10.1111/jvh.13071
复制
发表时间：
2019-06-01
影响因子：
2.5
通讯作者：
Irving, William L.
中科院分区：
文献类型：
--
作者：
Jack, Kathryn;Thomson, Brian J.;Irving, William L.
监狱是根除丙型肝炎病毒（HCV）这一主要公共卫生威胁的关键人群。我们已经评估了最近推出的国家退出政策的影响，在东米德兰兹郡（英国）的14所监狱的HCV检测的现状。我们分析了引入选择退出测试之前和之后的测试率，以及与每个监狱的监狱医疗保健和管理人员的面对面访谈。在选择退出前的一年，有1972名囚犯接受了测试，而在选择退出后的一年，有3440人接受了测试。从2016年7月到2017年6月，2706人接受了测试，占所有监狱进入者的13.5%（中位数16.6%，范围7.6%-40.7%）。与检测率相关的因素有：入院前PIP所在地（另一所监狱或社区，OR2.2，95%CI1.9 -2.3，P
Prisons are a key demographic in the drive to eradicate hepatitis C virus (HCV) as a major public health threat. We have assessed the impact of the recently introduced national opt-out policy on the current status of HCV testing in 14 prisons in the East Midlands (UK). We analysed testing rates pre- and post-introduction of opt-out testing, together with face-to-face interviews with prison healthcare and management staff in each prison. In the year pre-opt-out, 1972 people in prison (PIP) were tested, compared to 3440 in the year following opt-out. From July 2016 to June 2017, 2706 people were tested, representing 13.5% of all prison entrants (median 16.6%, range 7.6%-40.7%). Factors correlating with testing rates were as follows: pre-admission location of the PIP (another prison or the community, OR 2.2, 95% CI 1.9-2.3, P